Neurescue

Neurescue is a Danish medical device company based in Copenhagen, founded in 2014. The company specializes in developing innovative cardiovascular devices aimed at enhancing emergency patient outcomes, particularly during cardiac arrest. Its flagship product, the NEURESCUE device, is the world’s first intelligent, fluoroscopy-free balloon catheter designed for temporary aortic occlusion. This device is inserted through the femoral artery to temporarily block blood flow in the descending aorta, significantly increasing blood flow to the heart and brain during critical emergencies. Neurescue primarily serves healthcare providers, emergency medical services, and hospitals through a B2B and B2G business model. The company generates revenue from direct sales of its device, as well as from disposable components and maintenance services. With a focus on ease of use and rapid deployment, Neurescue aims to improve survival rates in cardiac arrest and critical bleeding scenarios. The company has received substantial funding, including a €6.7 million Series A round and support from the EU Horizon 2020 program, reflecting its commitment to advancing emergency cardiovascular care.

• Employees 15
• Founded 2014
• Total Funding $11003281